Health24.com | Coronavirus morning update: Concerns over lab backlogs, Covid-19 parole – only certain inmates eligible

WHAT’S HAPPENING IN SA

Cases update: 

The latest number of confirmed cases is 8 895.

According to the latest update, 178 deaths have been recorded in the country.

So far, 307 752 tests have been conducted, with nearly 15 600 new tests.

READ MORE | All the confirmed cases of coronavirus in SA

Latest news:

Only offenders who committed petty crimes will be eligible to be included in the 19 000 inmates who will be released on parole to combat the spread of Covid-19 in prisons.

Justice Minister Ronald Lamola and Correctional Services Commissioner Arthur Fraser briefed the media on Friday on President Cyril Ramaphosa’s announcement that he had authorised the release of low-risk inmates who have already served their minimum sentence, or who would approach this period in the next five years.

Lamola said that approximately 19 000 inmates across the country would benefit from this decision, provided they met requirements of the parole board.

“They will be considered on a case-by-case basis and those who qualify will be placed on parole after all the due processes including Victim Offender Dialogues, have accordingly unfolded,” Lamola said.

The only inmates that are eligible for release are those who were convicted and imprisoned for petty crimes. Fraser described it as crimes of need.

These types of crimes include shoplifting, theft and trespassing.

READ MORE | Covid-19 in prisons: Only inmates convicted of petty crimes will go free, says Lamola

Delays in results have left many fearing infected patients, who should otherwise be self-quarantining, could unwittingly be exposing others to the virus.

“The delay is not only being experienced in the Western Cape,” says provincial health department spokesperson Nomawethu Sbukwana.

“As the Western Cape – and indeed other provinces – ramp up testing, [the National Health Laboratory Services] are finding it challenging to keep up and process these tests, resulting in a nationwide backlog in the results.”

The Western Cape has become the epicentre of South Africa’s outbreak of the coronavirus, known as SARS-Cov-2.

Sbukwana said the department had contacted the National Health Laboratory Services (NHLS) to try to ramp up the testing capacity in the province.

READ MORE | National Covid-19 testing backlog means patients may wait up to 10 days for results

The DA has demanded the minutes of all discussions held by the National Coronavirus Command Council (NCCC), including the decision to continue the ban on tobacco products.

The party’s interim leader, John Steenhuisen, said the DA had filed an application in terms of the Promotion to Access to Information (PAIA) Act to get access to the records that have so far been described as classified.

He railed against the continuation of the “destructive lockdown” in its current form, which turned South Africans into “subjects of an authoritarian state”. 

Steenhuisen was speaking on Friday in an online “announcement of national importance”.

He said when President Cyril Ramaphosa announced South Africa would be placed under lockdown six weeks ago, it was the correct decision.

It was done to give South Africa time to prepare for its response to the pandemic, the DA leader added.

READ MORE | End lockdown now, or South Africans will end it for you – Steenhuisen to Ramaphosa

South Africa’s scaling up of Covid-19 testing in recent weeks appears to have resulted in severe capacity constraints at public sector laboratories, with doctors reporting that it is often taking a week or longer to get results.

“The current turnaround time for COVID-19 tests in Gauteng is around 7 days for outpatients and 3-4 days for in-patients,” says Dr Tom Boyles, an Infectious Diseases specialist at Helen Joseph Hospital in Johannesburg. He says that colleagues from the Eastern and Western Cape have reported similar delays.

A doctor who works at an emergency unit in a public sector hospital in Johannesburg confirmed to Spotlight that they are waiting seven days for Covid-19 test results. The doctor who asked not to be identified, says that the situation is very frustrating for clinicians.

In some of the worst cases, tests sent from their hospital were lost and no results were provided as long as three weeks after initial testing.The doctor says that testing delays are contributing to wards filling up, since they are not getting the results that would give the all-clear for patients to be discharged.

The doctor also suggested that the testing backlog may explain why the official count of confirmed cases in Gauteng is not rising more quickly at the moment. “I think it’s simply because we are not testing enough,” the doctor said.

READ MORE | Covid-19: Doctors concerned about severe testing delays

A few dozen people wearing homemade and medical masks sit waiting for taxis as drivers spray hand sanitiser on commuters and tell them where inside of the ubiquitous South African Toyota Quantum minibus taxis they may sit to keep the appropriate distance. 

The scene on this Friday morning is eerily quiet for Bosman taxi rank, usually one of Pretoria’s busiest and loudest spots. “The mood is very somber”, says Macdonald Makata, public relations officer of the South African National Taxi Council (SANTACO) in Tshwane.

Only about a fifth of the rank is operating, with vehicles filled to a maximum of 70%, sanitised regularly, and deep cleaned twice a week. All commuters are meant to wear masks, although only about half do, says Charles, who has been a taxi driver for about five years.

“It’s very difficult that(sic) but we have to follow,” he says of the regulations. Makata agrees that while the health measures are important, they are not easy to implement, since some commuters do not take them seriously and it is having a great financial impact on the industry. “In a way it is helping to flatten the curve,” he says, “but pocket-wise it is not helpful at all.”

READ MORE | Covid-19: What should public transport look like?

WHAT’S HAPPENING IN THE REST OF THE WORLD 

Cases update:

For the latest global data, follow this interactive map from Johns Hopkins University & Medicine.

Late on Friday night, positive cases worldwide were more than 3.9 million, while deaths were almost 274 000.

The United States had the most cases in the world – more than 1.28 million , as well as the most deaths – close to 77 000.

READ MORE | All the confirmed cases worldwide

Latest news:

A study performed in New York hospitals found no evidence of either harm or benefit from giving the malaria drug hydroxychloroquine to severely ill coronavirus patients.

“The risk of intubation or death was not significantly higher or lower among patients who received hydroxychloroquine than among those who did not,” the authors of the study said.

They said the study, published on Thursday in The New England Journal of Medicine, “should not be taken to rule out either benefit or harm of hydroxychloroquine treatment.”

“However, our findings do not support the use of hydroxychloroquine at present, outside randomised clinical trials testing its efficacy,” they said.

US President Donald Trump has frequently touted the use of hydroxychloroquine as a treatment for coronavirus patients.

READ MORE | No apparent harm or benefit from hydroxychloroquine – study

China said on Friday it supports a World Health Organisation-led review into the global response to the coronavirus outbreak, but only “after the pandemic is over”.

The comments from foreign ministry spokesperson Hua Chunying came as China faces increasing global pressure to allow an international investigation into the origins of the pandemic.

The review should be conducted in an “open, transparent and inclusive manner” under the leadership of WHO chief Tedros Adhanom Ghebreyesus, Hua said at a press briefing.

She added that it should be at an “appropriate time after the pandemic is over”.

But Hua did not say the review should probe the origins of the virus, despite growing calls led by the US and Australia for an international inquiry into the issue, which has become a key flashpoint in deteriorating tensions between Washington and Beijing.

READ MORE | China supports WHO-led review of global pandemic response

LATEST RESEARCH

We can’t help liking llamas with their fluffy faces and spindly legs.

But it seems that the llama has now become significant for a particular reason – its blood contains an antibody that could potentially neutralise SARS-CoV-2.

A new study published in the journal Cell on Tuesday 5 May 2020 stated that these antibodies can help neutralise the novel coronavirus, known for causing Covid-19. 

This comes from research of four years ago. The international research team found that the antibodies from a then nine-month-old llama named Winter could neutralise both SARS-CoV-1 and Mers-Cov over a period of six weeks.

Both these coronaviruses were known for causing outbreaks in 2003 and 2012. Now, SARS-CoV-2 is sweeping across the globe with dire consequences.

READ MORE | How a llama named Winter could help fight Covid-19

With the Covid-19 pandemic placing unprecedented demands on hospitals around the world, health authorities worry about an insufficient supply of ventilators, beds and staff to help those infected.

Countries experiencing a shortage of these include South Sudan, Somalia and Venezuela. And to manage this crisis and establish hospital readiness in South Africa, Trixta, a collaborative low-code platform for business minds and software developers, have launched ReportCovidCase.com – a web app that was built in just 72 hours, and gives hospitals an indicator of how many cases they will have in the near future.

This initiative came after the company was approached by a private GP helping out at a well-known Cape Town hospital, expressing concerns about the lack of information about Covid-19 cases reaching hospitals. 

This prevents healthcare workers from knowing how many ventilators, beds and staff are required.

READ MORE | Local company builds Covid-19 hospital tracking solution in 72 hours

As the current number of Covid-19 cases keeps rising across the globe, researchers aren’t only concerned about finding a vaccine or effective treatment – they also want to track the virus to find out how it spreads, mutates and adapts over time.

A team from Arizona State University (ASU) lead by Efrim Lim, assistant professor at ASU’s Biodesign Institute, traced the trail of the virus across the world by using advanced technology that can decode the entire genetic code of SARS-CoV-2.

Their research was announced in a news release and published in the Journal of Virology.

What is genome sequencing and why is it important?

We’ve been hearing the term “genome sequencing” frequently in coronavirus-related content, but it’s often hard to understand, especially if you are not an expert in epidemiology.

Genome sequencing is the process of “figuring out” the exact order of DNA nucleotides in a virus, almost like letters in a sentence, but without punctuation and capitals.

READ MORE | Research team finds new, unique mutation in coronavirus

HEALTH TIPS (as recommended by the NICD and WHO)

• Maintain physical distancing – stay at least one metre away from somebody who is coughing or sneezing

• Practise frequent hand-washing, especially after direct contact with ill people or their environment

• Avoid touching your eyes, nose and mouth, as your hands touch many surfaces and could potentially transfer the virus

• Practise respiratory hygiene – cover your mouth with your bent elbow or tissue when you cough or sneeze. Remember to dispose the tissue immediately after use.

READ MORE: Coronavirus 101 

Image credit: Getty Images

Share Button

Coronavirus: Why might the R number be higher in Scotland?

The R-value is at the heart of decisions on easing the lockdown – so why might it be different north of the border?

Share Button

Coronavirus: Young men ‘more likely to ignore lockdown’

Psychologists find they are more likely to meet friends than women.

Share Button

Individualized mosaics of microbial strains transfer from the maternal to the infant gut

Microbial communities in the intestine — also known as the gut microbiome — are vital for human digestion, metabolism and resistance to colonization by pathogens. The gut microbiome composition in infants and toddlers changes extensively in the first three years of life. But where do those microbes come from in the first place?

Scientists have long been able to analyze the gut microbiome at the level of the 500 to 1,000 different bacterial species that mainly have a beneficial influence; only more recently have they been able to identify individual strains within a single species using powerful genomic tools and supercomputers that analyze massive amounts of genetic data.

Researchers at the University of Alabama at Birmingham now have used their microbiome “fingerprint” method to report that an individualized mosaic of microbial strains is transmitted to the infant gut microbiome from a mother giving birth through vaginal delivery. They detailed this transmission by analyzing existing metagenomic databases of fecal samples from mother-infant pairs, as well as analyzing mouse dam and pup transmission in a germ-free, or gnotobiotic, mouse model at UAB, where the dams were inoculated with human fecal microbes.

“The results of our analysis demonstrate that multiple strains of maternal microbes — some that are not abundant in the maternal fecal community — can be transmitted during birth to establish a diverse infant gut microbial community,” said Casey Morrow, Ph.D., professor emeritus in UAB’s Department of Cell, Developmental and Integrative Biology. “Our analysis provides new insights into the origin of microbial strains in the complex infant microbial community.”

The study used a strain-tracking bioinformatics tool previously developed at UAB, called Window-based Single-nucleotide-variant Similarity, or WSS. Hyunmin Koo, Ph.D., UAB Department of Genetics and Genomics Core, led the informatics analysis. The gnotobiotic mouse model studies were led by Braden McFarland, Ph.D., assistant professor in the UAB Department of Cell, Developmental and Integrative Biology.

Morrow and colleagues have used this microbe fingerprint tool in several previous strain-tracking studies. In 2017, they found that fecal donor microbes — used to treat patients with recurrent Clostridium difficile infections — remained in recipients for months or years after fecal transplants. In 2018, they showed that changes in the upper gastrointestinal tract through obesity surgery led to the emergence of new strains of microbes. In 2019, they analyzed the stability of new strains in individuals after antibiotic treatments, and earlier this year, they found that adult twins, ages 36 to 80 years old, shared a certain strain or strains between each pair for periods of years, and even decades, after they began living apart from each other.

In the current study, several individual-specific patterns of microbial strain-sharing were found between mothers and infants. Three mother-infant pairs showed only related strains, while a dozen other infants of mother-infant pairs contained a mosaic of maternal-related and unrelated microbes. It could be that the unrelated strains came from the mother, but they had not been the dominant strain of that species in the mother, and so had not been detected.

Indeed, in a second study using a dataset from nine women taken at different times in their pregnancies showed that strain variations in individual species occurred in seven of the women.

To further define the source of the unrelated strains, a mouse model was used to look at transmission from dam to pup in the absence of environmental microbes. Five different females were given transplants of different human fecal matter to create five unique humanized-microbiome mice, which were bred with gnotobiotic males. The researchers then analyzed the strains found in the human donors, the mouse dams and their mouse pups. They found four different patterns: 1) The pup’s strain of a particular species was related to the dam’s strain; 2) The pup’s strain was related to both the dam’s strain and the human donor’s strain; 3) The pup’s strain was related to the human donor’s strain, but not to the dam’s strain; and, importantly, 4) No related strains for a particular species were found between the pup, the dam and the human donor. Since these animals were bred and raised in germ-free conditions, the unrelated strains in the pups came from minor, undetected strains in the dams.

“The results of our studies support a reconsideration of the contribution of different maternal microbes to the infant enteric microbial community,” Morrow said. “The constellation of microbial strains that we detected in the infants inherited from the mother was different in each mother-infant pair. Given the recognized role of the microbiome in metabolic diseases such as obesity and type 2 diabetes, the results of our study could help to further explain the susceptibility of the infant to metabolic disease found in the mother.”

Story Source:

Materials provided by University of Alabama at Birmingham. Original written by Jeff Hansen. Note: Content may be edited for style and length.

Share Button

The role of European policy for improving power plant fuel efficiency

A new study published in the Journal of the Association of Environmental and Resource Economists investigates the impact of the European Union Emissions Trading Scheme (EU ETS), the largest international cap-and-trade system for greenhouse gas emissions in the world, on power plant fuel efficiency.

In “The European Union Emissions Trading Scheme and Fuel Efficiency of Fossil Fuel Power Plants in Germany” author Robert Germeshausen studies German power plants and finds that a reduction in fuel use by fossil fuel power plants due to the introduction of the EU ETS translates into reductions in total annual carbon emissions of about 1.5 to 2 percent within the German power sector.

To put this improvement into context, this decrease in fuel input on average is equivalent to a reduction of around four to six million tons in annual carbon emissions. The results point to the role of actual investment in generation technology to improve fuel efficiency as Germeshausen finds positive effects on large investments in machinery.

The power sector is central to climate protection strategies, including those in Germany, where it accounts for around 40 percent of total annual carbon emissions. The Intergovernmental Panel on Climate Change states that reducing the carbon intensity of electricity generation (also known as decarbonizing) is a key component of cost-effective mitigation strategies. “Hence, understanding the effects of existing climate policies on the power sector is crucial for the further development of policies to achieve mitigation targets efficiently,” writes Germeshausen.

The EU ETS puts a price on greenhouse gas emissions from regulated installations to achieve emission reductions and to provide incentives for investments in low-carbon technologies. Germeshausen utilizes administrative annual plant-level data covering around 85 percent of fossil fuel electricity generation in Germany from 2003 to 2012. Germany’s electricity generation fleet consists of a variety of hard coal, lignite, nuclear, and natural gas power plants as well as renewable energy installations.

Germeshausen draws conclusions on the effect of carbon pricing on the optimal input combination in electricity generation and also on fuel efficiency improvements as a measure to reduce carbon emissions in the power sector. He additionally analyzes potential effects on labor efficiency, investments in machinery, and utilization of power plants.

Unlike previous studies on productivity and efficiency effects from policies and regulation in the electricity generation sector, which focus mainly on the effects of deregulation on productivity and efficiency, this study differs with respect to the nature of the influence. “Understanding the impacts on regulated entities is crucial for the assessment and the further development of mitigation policies such as emission trading schemes,” Germeshausen writes. Given the high variable cost share of fuel in power generation, the introduction of a carbon price may provide carbon intensive power plants with an incentive to improve fuel efficiency.

Germeshausen finds that the ETS negatively impacts the capacity factor, i.e., carbon intensive plants produce less output in relation to their potential output compared to less carbon intensive plants. “Thus, the effect should be interpreted as a positive net effect on fuel efficiency, exceeding a potential negative fuel efficiency effect from decreased utilization of carbon intensive power plants.”

Story Source:

Materials provided by University of Chicago Press Journals. Note: Content may be edited for style and length.

Share Button

Seahorse and pipefish study opens window to marine genetic diversity

The direction of ocean currents can determine the direction of gene flow in rafting species, but this depends on species traits that allow for rafting propensity. This is according to a City College of New York study focusing on seahorse and pipefish species. And it could explain how high genetic diversity can contribute to extinction in small populations.

Published in the British-based journal Proceedings of the Royal Society B, the paper by City College scientists led by Michael Hickerson and Laura Bertola is entitled: “Asymmetrical gene flow in five co-distributed syngnathids explained by ocean currents and rafting propensity.”

It reveals that ocean circulation driving macro-algal rafting is believed to serve as an important mode of dispersal for many marine organisms. This leads to predictions on population-level genetic connectivity and the directionality of effective dispersal.

The CCNY Division of Sciences researchers used genome-wide single nucleotide polymorphism data to investigate whether gene flow directionality in two seahorses (Hippocampus) and three pipefishes (Syngnathus) follows the predominant ocean circulation patterns in the Gulf of Mexico and northwestern Atlantic. They also explored whether gene flow magnitudes are predicted by traits related to active dispersal ability and habitat preference.

“We inferred demographic histories of these co-distributed syngnathid species, and coalescent model-based estimates indicate that gene flow directionality is in agreement with ocean circulation data that predicts eastward and northward macro-algal transport,” said Hickerson. “However, the magnitude to which ocean currents influence this pattern appears strongly dependent on the species-specific traits related to rafting propensity and habitat preferences.”

The study, he said, highlights how the combination of population genomic inference together with ocean circulation data can help explain patterns of population structure and diversity in marine ecosystems.

Story Source:

Materials provided by City College of New York. Note: Content may be edited for style and length.

Share Button

Health24.com | No apparent harm or benefit from hydroxychloroquine – study

A study performed in New York hospitals found no evidence of either harm or benefit from giving the malaria drug hydroxychloroquine to severely ill coronavirus patients.

“The risk of intubation or death was not significantly higher or lower among patients who received hydroxychloroquine than among those who did not,” the authors of the study said.

They said the study, published on Thursday in The New England Journal of Medicine, “should not be taken to rule out either benefit or harm of hydroxychloroquine treatment.”

“However, our findings do not support the use of hydroxychloroquine at present, outside randomised clinical trials testing its efficacy,” they said.

US President Donald Trump has frequently touted the use of hydroxychloroquine as a treatment for coronavirus patients.

No significant association

Hydroxychloroquine and a related compound chloroquine have been used for decades to treat malaria, as well as the autoimmune disorders lupus and rheumatoid arthritis.

The observational study was conducted among emergency room patients at the New York-Presbyterian Hospital and Columbia University Irving Medical Center and funded by the National Institutes of Health.

For the study, 811 patients received two doses of 600mg of hydroxychloroquine on the first day and 400 mg daily for four days.

Another 565 patients did not receive the drug.

Comparing the two groups, “there was no significant association between hydroxychloroquine use and intubation or death,” the study said.

Health Canada, the European Medicines Agency and the US Food and Drug Administration have warned against the use of hydroxychloroquine to treat Covid-19 outside of clinical trial

US regulators last week authorized the emergency use of the experimental drug remdesivir against Covid-19 after it was shown in a major clinical trial to shorten the time to recovery in some coronavirus patients.

READ | Coronavirus | The chloroquine debate: Two experts weigh in

READ | Covid-19: The problems caused by the chloroquine and hydroxychloroquine hype

READ | More evidence that Trump-touted drugs won’t curb Covid-19

Image credit: Getty Images

Share Button

Newly discovered cell type plays crucial role in immune response to respiratory infections

With a discovery that could rewrite the immunology textbooks, an international group of scientists, including the teams of Bart Lambrecht, Martin Guilliams, Hamida Hammad, and Charlotte Scott (all from the VIB-UGent Center for Inflammation Research) identified a new type of antigen-presenting immune cell. These cells, that are part of an expanding family of dendritic cells, play a crucial role presenting antigens to other immune cells during respiratory virus infections, and could explain how convalescent plasma helps to boost immune responses in virus-infected patients.

Inflammation and immunity

When our body faces an infection, it responds with inflammation and fever. This is a sign that the immune system does its work, and leads to the activation of many cells, like soldiers in an army. Dendritic cells (DCs) are the generals of that army. They can precisely activate and instruct the soldiers to kill infected cells by presenting antigens derived from the ‘invaders’ to cells of the immune system.

Mistaken identity

There are several types of DCs that perform antigen-presenting functions in the body. A first type of conventional DCs continuously scan the body for dangerous invaders, even when there is no infection. When there is inflammation triggered by infection, another subset of DCs emerges from inflammatory monocytes. Because monocyte-derived DCs are easily prepared in vitro from monocytes isolated form human blood, it was always assumed these cells were very important antigen-presenting cells. Clinical trials using monocyte-derived DCs in cancer therapy have however been disappointing.

A study by the teams of Bart Lambrecht, Martin Guilliams, Hamida Hammad, and Charlotte Scott (all from the VIB-UGent Center for Inflammation Research) and international colleagues, shows that monocyte-derived DCs are poor antigen-presenting cells, but have wrongly been assumed to have these functions because of a case of mistaken identity.

The scientists studied mice with a viral respiratory infection (pneumonia virus of mice and influenza virus) with single-cell technologies. This single-cell resolution allowed them to finely separate the monocyte-derived cells from other DCs during their response to the infection. They found that monocyte-derived DCs do exist, but actually do not present antigens. The reason for all the confusion in the past is that a look-alike new DC emerges — called inflammatory type 2 conventional DC, or inf-cDC2 — that combines some of the best characteristics of monocytes, macrophages, and conventional DCs, to induce the best form of immunity.

Bart Lambrecht: “This was a big surprise for us. We’ve all been taught that monocyte-derived cells are excellent antigen presenting cells, certainly when there’s inflammation. Now, we show that it’s actually a new hybrid DC type that’s doing all the work. This really changes what we know about the immune system and is very important knowledge for understanding respiratory viral infections and other inflammatory diseases.”

Martin Guilliams: “It took a massive team effort but the strength of single-cell sequencing has finally cracked the complex DC code. Many contradicting findings from the last two decades now make much more sense. This also opens tremendous therapeutic opportunities, since vaccination strategies can now be designed to trigger formation of inf-cDC2s and thus generate a stronger antiviral immune response.”

Charlotte Scott: “Through the use of single cell technologies we have been able to align all the findings from the past few years and identify the distinct cell types involved. Moving forward it will be very interesting to see under what other inflammatory conditions these inf-cDC2s are generated and how they can potentially be targeted therapeutically.”

Convalescent plasma and COVID-19

The findings of the researchers also have a direct relevance for the current COVID-19 pandemic, caused by another respiratory virus. An emergency treatment that is currently being explored is the use of convalescent plasma, or the blood plasma of recovered patients.

Cedric Bosteels, lead author of the new paper: “One of the unique features of the new DCs is that they express functional Fc receptors for antibodies that are found in the plasma of patients who have recovered from COVID-19”

This study is the first to show that one of the mechanisms through which convalescent plasma and the virus-specific antibodies in it work, is via boosting of inf-cDC2. Since boosted DCs induce a much stronger immune response, this study reveals a new target for therapeutic intervention for viral infections and other inflammatory diseases.

Funding

This study was funded by the European Research Council, University Ghent, Research Foundation Flanders (FWO), and the Health Research Council New Zealand.

Share Button

Flies sleep when need arises to adapt to new situations

Flies that cannot take to the air respond by sleeping more as they learn to adapt to their flightlessness, according to a study from Washington University School of Medicine in St. Louis. The findings, published May 8 in Science Advances, suggest that sleep may be an evolutionary tool that helps animals adapt to challenging new situations.

“We know that sleep is involved in creativity and insight,” said senior author Paul Shaw, PhD, a professor of neuroscience. “Have you ever slept on a problem, and when you wake up you’ve found the answer? Anxiety keeps people up at night, but if you find yourself in a dangerous environment, or in a situation that you don’t know how to deal with, sleep may be exactly what you need to respond to it effectively.”

Fruit flies’ sleep looks a lot like people’s. Baby flies need a lot of sleep, but as they get older, their need for sleep diminishes. Flies become more alert with caffeine and drowsier with antihistamines. And if you keep a fly awake one day, it will sleep more the next.

These similarities suggest that the sleep habits of flies might shed light on the sleep habits of people. To explore the relationship between challenging circumstances and sleep, Shaw and staff scientist and first author Krishna Melnattur, PhD, took away flies’ ability to fly.

Baby flies must expand their wings in the first half hour or so after emerging from pupal cases, or their wings will not develop properly. The researchers placed some newly emerged flies in tiny containers so they could not expand their wings, and they genetically modified other flies so that the insects’ wings failed to expand. Both scenarios rendered the young flies permanently flightless. The researchers also grounded older flies by disabling their wings. In all cases, faced with the inability to fly, the animals slept more than usual.

In subsequent experiments, the researchers traced the neurological circuit that signals to the brain that the wings aren’t functioning and triggers the impulse to sleep more.

“When we identified the neurons that were activated when we cut or glued the wings of adult flies, they turned out to be the same neurons involved in the normal developmental process of wing expansion after emergence,” Melnattur said.

The fact that wing injury and normal wing development are linked to sleep through the same neurological circuitry makes sense from an evolutionary standpoint, the researchers said. The circuit is active in young flies because their developing brains need sleep as the animals expand their wings, learn to fly and begin to navigate the world around them.

“And then the whole circuit can get reactivated later in life when something happens that forces a fly to adapt to a new normal,” Shaw said. “Suddenly, its brain needs to be as flexible as when it was young. It can no longer fly, but it still needs to get food, it needs to compete for mates, it needs to avoid dying. We think that sleep amplifies the brain plasticity the fly needs to survive.”

Shaw and Melnattur are planning experiments to determine whether increased sleep helps flightless flies survive. Their findings also may provide clues to why some people sleep more than others and why some sleep disorders arise.

“There’s huge variation in sleep time among people,” Shaw said. “Some people need five hours a night; some need nine. Sleep is an ancient process, and we’ve evolved mechanisms to change our sleep-wake balance to help us meet our needs. If these mechanisms get inappropriately activated, say by a traumatic event that triggers post-traumatic stress disorder, it can create a situation in which you’re sleeping too much or too little and it’s no longer matching up with your needs, and then you have a sleep disorder.”

Story Source:

Materials provided by Washington University School of Medicine. Original written by Tamara Bhandari. Note: Content may be edited for style and length.

Share Button

Inspired by cheetahs, researchers build fastest soft robots yet

Inspired by the biomechanics of cheetahs, researchers have developed a new type of soft robot that is capable of moving more quickly on solid surfaces or in the water than previous generations of soft robots. The new soft robotics are also capable of grabbing objects delicately — or with sufficient strength to lift heavy objects.

“Cheetahs are the fastest creatures on land, and they derive their speed and power from the flexing of their spines,” says Jie Yin, an assistant professor of mechanical and aerospace engineering at North Carolina State University and corresponding author of a paper on the new soft robots.

“We were inspired by the cheetah to create a type of soft robot that has a spring-powered, ‘bistable’ spine, meaning that the robot has two stable states,” Yin says. “We can switch between these stable states rapidly by pumping air into channels that line the soft, silicone robot. Switching between the two states releases a significant amount of energy, allowing the robot to quickly exert force against the ground. This enables the robot to gallop across the surface, meaning that its feet leave the ground.

“Previous soft robots were crawlers, remaining in contact with the ground at all times. This limits their speed.”

The fastest soft robots until now could move at speeds of up to 0.8 body lengths per second on flat, solid surfaces. The new class of soft robots, which are called “Leveraging Elastic instabilities for Amplified Performance” (LEAP), are able to reach speeds of up to 2.7 body lengths per second — more than three times faster — at a low actuation frequency of about 3Hz. These new robots are also capable of running up steep inclines, which can be challenging or impossible for soft robots that exert less force against the ground.

These “galloping” LEAP robots are approximately 7 centimeters long and weigh about 45 grams.

The researchers also demonstrated that the LEAP design could improve swimming speeds for soft robots. Attaching a fin, rather than feet, a LEAP robot was able to swim at a speed of 0.78 body lengths per second, as compared to 0.7 body lengths per second for the previous fastest swimming soft robot.

“We also demonstrated the use of several soft robots working together, like pincers, to grab objects,” Yin says. “By tuning the force exerted by the robots, we were able to lift objects as delicate as an egg, as well as objects weighing 10 kilograms or more.”

The researchers note that this work serves as a proof of concept, and are optimistic that they can modify the design to make LEAP robots that are even faster and more powerful.

“Potential applications include search and rescue technologies, where speed is essential, and industrial manufacturing robotics,” Yin says. “For example, imagine production line robotics that are faster, but still capable of handling fragile objects.

“We’re open to collaborating with the private sector to fine-tune ways they can incorporate this technology into their operations.”

The work was done with support from the National Science Foundation under grants 2010717 and 2005374.

Story Source:

Materials provided by North Carolina State University. Note: Content may be edited for style and length.

Share Button